Skip to main content
Log in

Extracorporeal renal and liver support in pediatric acute liver failure

  • Educational Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The liver is the only organ which can regenerate and, thus, potentially negate the need for transplantation in acute liver failure (ALF). Cerebral edema and sepsis are leading causes of mortality in ALF. Both water-soluble and protein-bound toxins have been implicated in pathogenesis of various ALF complications. Ammonia is a surrogate marker of water-soluble toxin accumulation in ALF and high levels are associated with higher grades of hepatic encephalopathy, raised intracranial pressure, and mortality. Therefore, extracorporeal therapies aim to lower ammonia and maintain fluid balance and cytokine homeostasis. The most common and easily available modality is continuous kidney replacement therapy (CKRT). Early initiation of high-volume CKRT utilizing an anticoagulation regimen minimizing treatment downtime and delivering the prescribed dose is highly desirable. Ideally, extracorporeal liver-assist devices (ECLAD) should perform both synthetic and detoxification functions of the liver. ECLAD may temporarily replace lost liver function and serve as a bridge, either to spontaneous recovery or liver transplantation. Various bioartificial and biologic liver-assist devices are described in specialty literature, including molecular adsorbent recirculating system (MARS), single pass albumin dialysis (SPAD), and total plasma exchange (TPE); however, clinicians commonly use modalities easily available in intensive care units. There is a lack of standardization of indications for ECLAD, availability of different extracorporeal devices with varied technical approaches, and, of note, the differences in doses of ECLAD provided in clinical practice. We review the practicalities and evidence regarding these four artificial liver support devices in pediatric ALF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Squires RHJ, Rand EB, Hoppin AG (2020) Acute liver failure in children: etiology and evaluation. https://www.uptodate.com/contents/acute-liver-failure-in-children-etiology-and-evaluation. Accessed 4 Jan 2020

  2. Bernal W, Lee WM, Wendon J, Larsen FS, Williams R (2015) Acute liver failure: a curable disease by 2024? J Hepatol 62(1 Suppl):S112–S120

    Article  PubMed  Google Scholar 

  3. Gazzard BG, Weston MJ, Murray-Lyon IM, Flax H, Record CO, Williams R, Portmann B, Langley PG, Dunlop EH, Mellon PJ, Ward MB (1974) Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1(7870):1301–1307

    Article  CAS  PubMed  Google Scholar 

  4. Loening WE, Coovadia HM, Parent MA (1974) Exchange transfusion in fulminant hepatic failure in children. S Afr Med J 48:128–130

    CAS  PubMed  Google Scholar 

  5. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148:652–658

    Article  PubMed  PubMed Central  Google Scholar 

  6. Coltart I, Tranah TH, Shawcross DL (2013) Inflammation and hepatic encephalopathy. Arch Biochem Biophys 536:189–196

    Article  CAS  PubMed  Google Scholar 

  7. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46:1844–1852

    Article  CAS  PubMed  Google Scholar 

  8. Wendon J, Lee W (2008) Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care 9:97–102

    Article  CAS  PubMed  Google Scholar 

  9. Warrillow SJ (2010) Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on outcome MELD away? Crit Care Med 38:2259–2260

    Article  PubMed  Google Scholar 

  10. Larsen FS, Wendon J (2008) Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 14(Suppl 2):S90–S96

    Article  PubMed  Google Scholar 

  11. Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, Rela M, Heaton N, O'Grady JG, Wendon J, Williams R (2013) Lessons from look-back in acute liver failure. a single-centre experience of 3300 patients. J Hepatol 59:74–80

    Article  PubMed  Google Scholar 

  12. Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P (2004) In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 39:1408–1414

    Article  CAS  PubMed  Google Scholar 

  13. Schultheiß C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwächter H, Schmid RM, Huber W (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ellis D, Avner ED, Starzl TE (1986) Renal failure in children with hepatic failure undergoing liver transplantation. J Pediatr 108:393–398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bridges BC, Askenazi DJ, Smith J, Goldstein SL (2012) Pediatric renal replacement therapy in the intensive care unit. Blood Purif 34:138–148

    Article  CAS  PubMed  Google Scholar 

  16. Tujios SR, Hynan LS, Vazquez MA, Larson AM, Seremba E, Sanders CM, Lee WM, Acute Liver Failure Study Group (2015) Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol 13:352–359

    Article  PubMed  Google Scholar 

  17. Kreuzer M, Gähler D, Rakenius AC, Prüfe J, Jack T, Pfister ED, Pape L (2015) Dialysis-dependent acute kidney injury in children with end-stage liver disease: prevalence, dialysis modalities and outcome. Pediatr Nephrol 30:2199–2206

    Article  PubMed  Google Scholar 

  18. Slack AJ, Auzinger G, Willars C, Dew T, Musto R, Corsili D, Sherwood R, Wendon JA, Bernal W (2013) Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 34:42–48

    Article  PubMed  CAS  Google Scholar 

  19. Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL (2013) High-dose continuous renal replacement therapy for neonatal hyperammonemia. Pediatr Nephrol 28:983–986

    Article  PubMed  PubMed Central  Google Scholar 

  20. Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732–738

    Article  PubMed  Google Scholar 

  21. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, Losowsky MS (1989) Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 53:142–146

    Article  CAS  PubMed  Google Scholar 

  22. Deep A, Stewart CE, Dhawan A, Douiri A (2016) Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 44:1910–1919

    Article  CAS  PubMed  Google Scholar 

  23. Sadamori H, Yagi T, Inagaki M, Shima Y, Matsuda H, Tanaka N, Sakaguchi K, Tsuji T, Matsumi M, Katayama H, Hirakawa N (2002) High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 14:435–439

    Article  PubMed  Google Scholar 

  24. Chevret L, Durand P, Lambert J, Essoouri S, Balu L, Devictor D, Tissieres P (2014) High-volume hemofiltration in children with acute liver failure*. Pediatr Crit Care Med 15:e300–e305

    Article  PubMed  Google Scholar 

  25. Habib M, Roberts LN, Patel RK, Wendon J, Bernal W, Arya R (2014) Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int 34:672–678

    Article  CAS  PubMed  Google Scholar 

  26. Goonasekera CD, Wang J, Bunchman TE, Deep A (2014) Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Apher Dial 19:16–22

    Article  PubMed  Google Scholar 

  27. Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819–824

    Article  PubMed  Google Scholar 

  28. Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208–212

    Article  PubMed  Google Scholar 

  29. Musielak A, Warzywoda A, Wojtalik M, Kociński B, Kroll P, Ostalska-Nowicka D, Zachwieja J (2016) Outcomes of continuous renal replacement therapy with regional citrate anticoagulation in small children after cardiac surgery: experience and protocol from a single center. Ther Apher Dial 20:639–644

    Article  PubMed  Google Scholar 

  30. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416–1421

    Article  PubMed  Google Scholar 

  31. MacLaren G, Butt W (2009) Controversies in paediatric continuous renal replacement therapy. Intensive Care Med 35:596–602

    Article  PubMed  Google Scholar 

  32. Jacobs R, Honoré PM, Bagshaw SM, Diltoer M, Spapen HD (2015) Citrate formulation determines filter lifespan during continuous veno-venous hemofiltration: a prospective cohort study. Blood Purif 40:194–202

    Article  CAS  PubMed  Google Scholar 

  33. Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41:2098–2110

    Article  CAS  PubMed  Google Scholar 

  34. Deep A, Zoha M, Dutta Kukreja P (2017) Prostacyclin as an anticoagulant for continuous renal replacement therapy in children. Blood Purif 43:279–289

    Article  CAS  PubMed  Google Scholar 

  35. Abe T, Kobata H, Hanba Y, Kitabata Y, Narukawa N, Hasegawa H, Abe T, Fukagawa M (2004) Study of plasma exchange for liver failure: beneficial and harmful effects. Ther Apher Dial 8:180–184

    Article  CAS  PubMed  Google Scholar 

  36. Schwartz J, Padmanabhan A, Aqui N, Baloqun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 31:149–162

    PubMed  Google Scholar 

  37. Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, Triantafyllou E, Bernal W, Auzinger G, Shawcross D, Eefsen M, Bjerring PN, Clemmesen JO, Hockerstedt K, Frederiksen HJ, Hansen BA, Antoniades CG, Wendon J (2015) High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64:69–78

    Article  PubMed  Google Scholar 

  38. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A (2001) Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 234:418–424

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Ide K, Muguruma T, Shinohara M, Toida C, Enomoto Y, Matsumoto S, Aoki K, Fukuda A, Sakamoto S, Kasahara M (2015) Continuous veno-venous hemodiafiltration and plasma exchange in infantile acute liver failure. Pediatr Crit Care Med 16:e268–e274

    Article  PubMed  Google Scholar 

  40. Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A (2017) Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One 12:e0182134

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Stefoni S, Colì L, Bolondi L, Donati G, Ruggeri G, Feliciangeli G, Piscaglia F, Silvagni E, Sirri M, Donati G, Baraldi O, Soverini ML, Cianciolo G, Boni P, Patrono D, Ramazzotti E, Motta R, Roda A, Simoni P, Magliulo M, Borgnino LC, Ricci D, Mezzopane D, Cappuccilli ML (2006) Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 29:207–218

    Article  CAS  PubMed  Google Scholar 

  42. Novelli G, Rossi M, Pretagostini R, Novelli L, Poli L, Ferretti G, Iappelli M, Berloco P, Cortesini R (2003) A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 23(Suppl 3):10–15

    Article  CAS  PubMed  Google Scholar 

  43. Donati G, La Manna G, Cianciolo G, Grandinetti V, Carretta E, Cappucilli M, Panicali L, Iorio M, Piscaglia F, Bolondi L, Colì L, Stefoni S (2013) Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs 38:125–134

    Article  PubMed  CAS  Google Scholar 

  44. Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V; RELIEF study group (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57:1153–1162

  45. Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, Barange K, Perrigault PF, Belnard M, Ichaï P, Samuel D (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 159:522–531

    Article  PubMed  Google Scholar 

  46. Schaefer B, Schmitt CP (2013) The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol 28:1763–1769

    Article  PubMed  Google Scholar 

  47. Lexmond WS, Van Dael CML, Scheenstra R, Goorhuis JF, Sieders E, Verkade HJ, Van Rheenen PF, Kömhoff M (2015) Experience with MARS treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl 21:369–380

    Article  PubMed  Google Scholar 

  48. Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, Novelli S, Spoletini G, Ferretti G, Mennini G, Berloco PB (2008) Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc 40:1921–1924

    Article  CAS  PubMed  Google Scholar 

  49. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP (2011) Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant 26:3633–3639

    Article  CAS  PubMed  Google Scholar 

  50. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Müllhaupt B, Renner EL (2007) Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 27:475–484

    Article  CAS  PubMed  Google Scholar 

  51. Rifai K, Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, Sarrazin C, Van Vlierberghe H, Hoste E, Escorsell À, Ginès P, Hafer C, Schuchmann M, Galle PR, Bernardi M, Caraceni P, Abeles D, Berr F, Knotek M, Kozik-Jaromin J, HELIOS Study Group (2010) Extracorporeal liver support by fractionated plasma separation and adsorption (prometheus) in patients with acute-on-chronic liver failure (HELIOS study): a prospective randomized controlled multicenter study. J Hepatol 52(Suppl 1):S3

    Article  Google Scholar 

  52. Ringe H, Varnholt V, Zimmering M, Luck W, Gratopp A, König K, Reich S, Sauer IM, Gaedicke G, Querfeld U (2011) Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med 12:257–264

    Article  PubMed  Google Scholar 

  53. Laleman W, Wilmer A, Evenepoel P, Vander Elst I, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10:R108

    Article  PubMed  PubMed Central  Google Scholar 

  54. Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D, Bauschke A, Settmacher U, Kohl M, Clemens MG, Mitzner S, Bauer M, Kortgen A (2016) Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study. Crit Care 20:2

    Article  PubMed  PubMed Central  Google Scholar 

  55. Filler G, Clark WF, Huang SH (2014) Tandem hemodialysis and plasma exchange. Pediatr Nephrol 29:2077–2082

    Article  PubMed  Google Scholar 

  56. Akcan Arikan A, Srivaths P, Himes R, Tufan Pekkucuksen N, Lam F, Nguyen T, Miloh T, Braun M, Goss J, Desai MS (2018) Hybrid extracorporeal therapies as a bridge to pediatric liver transplantation. Pediatr Crit Care Med 19:e342–e349

    Article  PubMed  Google Scholar 

  57. Schaefer B, Ujszaszi A, Schaefer S, Heckert KH, Schaefer F, Schmitt CP (2014) Safety and efficacy of tandem hemodialysis and plasma exchange in children. Clin J Am Soc Nephrol 9:1563–1570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Lee KCL, Stadlbauer V, Jalan R (2016) Extracorporeal liver support devices for listed patients. Liver Transpl 22:839–848

    Article  PubMed  Google Scholar 

  59. Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, Alhazzani W, GUIDE Group (2020) Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med 46:1–16

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akash Deep.

Additional information

Answers: 1. a, d; 2. a, b, c; 3. a, d; 4. e; 5. c, e

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zoica, B.S., Deep, A. Extracorporeal renal and liver support in pediatric acute liver failure. Pediatr Nephrol 36, 1119–1128 (2021). https://doi.org/10.1007/s00467-020-04613-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-020-04613-4

Keywords

Navigation